Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.220
+0.070 (3.26%)
At close: Jun 6, 2025, 4:00 PM
2.250
+0.030 (1.35%)
After-hours: Jun 6, 2025, 7:58 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Market Capitalization
919893471544640
Upgrade
Market Cap Growth
-26.11%4.69%-80.20%-13.48%-15.00%479.35%
Upgrade
Enterprise Value
-40-46-9311444565
Upgrade
Last Close Price
2.222.422.3112.0314.2819.68
Upgrade
PE Ratio
--16.87---
Upgrade
PS Ratio
45.43-69.54174.08200.54236.73
Upgrade
PB Ratio
0.640.670.573.113.265.49
Upgrade
P/TBV Ratio
0.640.670.573.103.275.53
Upgrade
EV/Sales Ratio
---115.15163.83208.87
Upgrade
Debt / Equity Ratio
0.000.000.320.010.000.01
Upgrade
Asset Turnover
0.01-0.010.02-0.03
Upgrade
Quick Ratio
23.8324.973.0527.1019.8514.10
Upgrade
Current Ratio
23.9425.193.0627.3420.0814.27
Upgrade
Return on Equity (ROE)
-18.51%-12.39%3.24%-23.77%--30.78%
Upgrade
Return on Assets (ROA)
-5.10%-4.25%-5.16%-14.95%--17.54%
Upgrade
Return on Capital (ROIC)
-5.29%-4.44%-5.38%-15.90%--20.18%
Upgrade
Earnings Yield
-31.14%-19.54%5.93%-7.77%-6.44%-3.48%
Upgrade
FCF Yield
-11.55%-8.64%-11.32%-6.04%-6.14%-3.37%
Upgrade
Buyback Yield / Dilution
0.05%-0.65%-4.02%-5.08%-30.36%-16.71%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q